We are live on ! Find out more
GCM

Graham Capital Management Portfolio holdings

AUM $4.14B
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+4.11%
1 Year Est. Return
+17.82%
3 Year Est. Return
+41.13%
5 Year Est. Return
+43.39%
10 Year Est. Return
+274.46%
AUM
$6.66B
AUM Growth
+$848M
Cap. Flow
-$1.13B
Cap. Flow %
-16.93%
Top 10 Hldgs %
57.62%
Holding
1,535
New
470
Increased
412
Reduced
291
Closed
336

Top Buys

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$35.5M
2
PEP icon
PepsiCo
PEP
+$19.5M
3
JNJ icon
Johnson & Johnson
JNJ
+$17.3M
4
AMZN icon
Amazon
AMZN
+$15.8M
5
SPGI icon
S&P Global
SPGI
+$14.3M

Top Sells

Rank Stock Value
1
IBIT icon
iShares Bitcoin Trust
IBIT
+$69.8M
2
GDX icon
VanEck Gold Miners ETF
GDX
+$21.3M
3
MSFT icon
Microsoft
MSFT
+$21.2M
4
WMT icon
Walmart Inc
WMT
+$17.1M
5
C icon
Citigroup
C
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 5.84%
2 Industrials 4.12%
3 Financials 3.46%
4 Consumer Discretionary 3.25%
5 Healthcare 2.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOSS icon
1176
Gossamer Bio
GOSS
$87M
$31.6K ﹤0.01%
+34,947
New +$29.9K
WTI icon
1177
W&T Offshore
WTI
$518M
$30.3K ﹤0.01%
18,268
-138,597
-88% -$277K
ADAP
1178
DELISTED
Adaptimmune Therapeutics
ADAP
$20K ﹤0.01%
37,195
+24,603
+195% +$17.9K
PGEN icon
1179
Precigen
PGEN
$2.59B
$15.2K ﹤0.01%
+13,612
New +$11.6K
ABT icon
1180
Abbott
ABT
$187B
-4,860
Closed -$554K
ACA icon
1181
Arcosa
ACA
$7.11B
-2,200
Closed -$208K
ACET icon
1182
Adicet Bio
ACET
$74.7M
-1,344
Closed -$31K
ADBE icon
1183
Adobe
ADBE
$105B
-574
Closed -$297K
ADP icon
1184
Automatic Data Processing
ADP
$108B
-12,955
Closed -$3.59M
ADUS icon
1185
Addus HomeCare
ADUS
$2.23B
-5,199
Closed -$692K
AER icon
1186
AerCap
AER
$23.8B
-2,909
Closed -$276K
AFRM icon
1187
Affirm
AFRM
$25.2B
-44,815
Closed -$1.83M
AGCO icon
1188
AGCO
AGCO
$7.2B
-4,063
Closed -$398K
AKAM icon
1189
Akamai
AKAM
$15.9B
-24,585
Closed -$2.48M
AKRO
1190
DELISTED
Akero Therapeutics
AKRO
-13,396
Closed -$384K
ALLY icon
1191
Ally Financial
ALLY
$13.3B
-6,660
Closed -$237K
ALXO icon
1192
ALX Oncology
ALXO
$290M
-96,849
Closed -$176K
AMBP icon
1193
Ardagh Metal Packaging
AMBP
$3.01B
-14,576
Closed -$55K
AMD icon
1194
CALL
Advanced Micro Devices
AMD
$789B
-300
Closed -$49.2K
AMH icon
1195
American Homes 4 Rent
AMH
$12.5B
-21,542
Closed -$827K
AMLX icon
1196
Amylyx Pharmaceuticals
AMLX
$2.54B
-67,956
Closed -$220K
AMSC icon
1197
American Superconductor
AMSC
$1.59B
-13,298
Closed -$314K
ANF icon
1198
Abercrombie & Fitch
ANF
$5B
-5,573
Closed -$780K
APH icon
1199
Amphenol
APH
$209B
-61,252
Closed -$3.99M
APLS
1200
DELISTED
Apellis Pharmaceuticals
APLS
-16,873
Closed -$487K

Similar funds

Graham Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Graham Capital Management held 1,535 positions worth $6.66B, up 15% from $5.81B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Graham Capital Management withdrew a net $1.13B in Q4 2024, closing 336 positions and reducing 291 holdings. Its most notable exit was VanEck Gold Miners ETF, an estimated $21.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.7% a quarter earlier, followed by Industrials and Financials.

Against the trend, Graham Capital Management opened a new position in Strategy Inc worth $34.1M.

  • Graham Capital Management's largest Q4 2024 buy was Strategy Inc: 117,912 shares worth $34.1M.
  • Graham Capital Management added most to Amazon in Q4 2024, an estimated $15.8M increase.
  • Graham Capital Management's biggest Q4 2024 reduction was iShares Bitcoin Trust, cutting an estimated $69.8M.
  • Graham Capital Management fully exited VanEck Gold Miners ETF in Q4 2024, selling an estimated $21.3M.
  • Graham Capital Management's ten largest holdings make up 58% of its $6.66B portfolio in Q4 2024.
  • Graham Capital Management opened 470 new positions and closed 336 in Q4 2024.
  • Graham Capital Management's portfolio value rose 15% quarter-over-quarter to $6.66B.

Based on Graham Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.